BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33145902)

  • 1. Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach.
    Popat S; Navani N; Kerr KM; Smit EF; Batchelor TJP; Van Schil P; Senan S; McDonald F
    Oncologist; 2021 Feb; 26(2):e306-e315. PubMed ID: 33145902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach.
    Bruni A; Giaj-Levra N; Ciammella P; Maragna V; Ferrari K; Bonti V; Grossi F; Greco S; Greco C; Borghetti P; Franceschini D; Capelletto E; Perna M; Banna G; Vagge S; Baldini E; Bria E; Botti A; Tiseo M; Paci M; Taraborrelli M; Poletti V; Granone P; Ricardi U; Novello S; Scotti V
    PLoS One; 2019; 14(11):e0224027. PubMed ID: 31721773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the pulmonologist in ordering post-procedure molecular markers in non-small-cell lung cancer: implications for personalized medicine.
    Murgu S; Colt H
    Clin Lung Cancer; 2013 Nov; 14(6):609-26. PubMed ID: 24188629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation Between Multidisciplinary Tumor Boards in Clinical Staging and Treatment Recommendations for Patients With Locally Advanced Non-small Cell Lung Cancer.
    Hoeijmakers F; Heineman DJ; Daniels JM; Beck N; Tollenaar RAEM; Wouters MWJM; Marang-van de Mheen PJ; Schreurs WH;
    Chest; 2020 Dec; 158(6):2675-2687. PubMed ID: 32738254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of multi-disciplinary team approach in diagnosis and management of Stage III NSCLC.
    Batra U; Munshi A; Kabra V; Momi G
    Indian J Cancer; 2022 Mar; 59(Supplement):S46-S55. PubMed ID: 35343190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.
    Choy H; Shyr Y; Cmelak AJ; Mohr PJ; Johnson DH
    Cancer; 2000 Mar; 88(6):1336-46. PubMed ID: 10717614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary Care of BRAF-Mutant Stage III Melanoma: A Physicians Perspective Review.
    Cornelius LA; Fields RC; Tarhini A
    Oncologist; 2021 Sep; 26(9):e1644-e1651. PubMed ID: 34080754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
    Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
    Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of oncologists in multidisciplinary cancer teams in the UK: an untapped resource for team leadership?
    Lamb B; Payne H; Vincent C; Sevdalis N; Green JS
    J Eval Clin Pract; 2011 Dec; 17(6):1200-6. PubMed ID: 20666886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
    Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide.
    Fox AH; Nishino M; Osarogiagbon RU; Rivera MP; Rosenthal LS; Smith RA; Farjah F; Sholl LM; Silvestri GA; Johnson BE
    CA Cancer J Clin; 2023; 73(4):358-375. PubMed ID: 36859638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings.
    Franceschini D; Bruni A; Borghetti P; Giaj-Levra N; Ramella S; Buffoni L; Badellino S; Andolina M; Comin C; Vattemi E; Bezzi M; Trovò M; Passaro A; Bearz A; Chiari R; Tindara F; Ferrari K; Piperno G; Filippi AR; Genovesi D; Scotti V
    Radiol Med; 2020 Feb; 125(2):214-219. PubMed ID: 31605353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Care for Patients With Stage III or IV NSCLC: Learnings for Multidisciplinary Teams From the ACCC National Quality Survey.
    Salgia R; Boehmer LM; Celestin C; Yu H; Spigel DR
    JCO Oncol Pract; 2021 Aug; 17(8):e1120-e1130. PubMed ID: 33689449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chinese expert consensus on the multidisciplinary clinical diagnosis and treatment of stage Ⅲ non-small cell lung cancer (2019)].
    ;
    Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):881-890. PubMed ID: 31874543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations.
    Göker E; Altwairgi A; Al-Omair A; Tfayli A; Black E; Elsayed H; Selek U; Koegelenberg C
    Lung Cancer; 2021 Aug; 158():60-73. PubMed ID: 34119934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary decision-making regarding chemotherapy for lung cancer patients-An age-based comparison.
    Schulkes KJG; Hamaker ME; Lammers JJ; van Rens MTM; Geerts M; van Elden LJR
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28940851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opinions of lung cancer clinicians on shared decision making in early-stage non-small-cell lung cancer.
    Mokhles S; Maat APWM; Aerts JGJV; Nuyttens JJME; Bogers AJJC; Takkenberg JJM
    Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):278-284. PubMed ID: 28449093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists.
    Mileham KF; Schenkel C; Bruinooge SS; Freeman-Daily J; Basu Roy U; Moore A; Smith RA; Garrett-Mayer E; Rosenthal L; Garon EB; Johnson BE; Osarogiagbon RU; Jalal S; Virani S; Weber Redman M; Silvestri GA
    Cancer Med; 2022 Jan; 11(2):530-538. PubMed ID: 34921524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP.
    Ospina AV; Bolufer Nadal S; Campo-Cañaveral de la Cruz JL; González Larriba JL; Macía Vidueira I; Massutí Sureda B; Nadal E; Trancho FH; Álvarez Kindelán A; Del Barco Morillo E; Bernabé Caro R; Bosch Barrera J; Calvo de Juan V; Casal Rubio J; de Castro J; Cilleruelo Ramos Á; Cobo Dols M; Dómine Gómez M; Figueroa Almánzar S; Garcia Campelo R; Insa Mollá A; Jarabo Sarceda JR; Jiménez Maestre U; López Castro R; Majem M; Martinez-Marti A; Martínez Téllez E; Sánchez Lorente D; Provencio M
    Clin Transl Oncol; 2024 Jul; 26(7):1647-1663. PubMed ID: 38530556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.